Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Wednesday, August 5, 2026

Snapshot: Aug 5, 2026 · 6:00 PM 100 stocks analyzed

Strong Up Day

Wed, Aug 5, 2026 Tech Rally Extreme

Nasdaq surged 7.9% in a tech-led rally with extreme single-stock dispersion as earnings beats drove gains up to 67%, while select weakness in solar and consumer names anchored l…

60% Tech dominated with Nasdaq up 7.9% and Russell 100 soaring 8.4%, as S&P 500 gained 5.6% in a broad tech rally; extreme dispersion saw 50 gainers averaging +29.5% (led by FWACW +67%, MGRX +58%, OESX +54%) against 50 losers averaging −28%, with news-grounded beats from APPS, MTRN, OESX, KLTR, and others powering the rally.
25% Earnings season delivered multiple monster beats across diverse sectors: MGRX +58% on Nucleea's nuclear microreactor MOU, OESX +54% on record EBITDA, APPS +39% on 27% revenue growth, FTK +28% on 70% YoY surge and $400M Puerto Rico contract, and VRM +35% on first profitable quarter, signaling broad operational improvement.
15% Losers revealed execution misses and sector weakness despite some positive headlines: SEDG −31% despite beating earnings on weak Q3 guidance, PODD −20% on Type 2 diabetes execution issues, and IPW −27% plus JUNS −25% on reverse splits signaling financial distress; two persistent losers GYGY and NXTT fell for a third consecutive day.

5 names returned after long absences GYGY · 3-day losers streak NXTT · 3-day losers streak OESX — first appearance GTE — first appearance

Market Regime

Wed, Aug 5, 2026 Risk-On conf: medium macro · prototype

+50

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.8 p13 Drawdown-0.2% Held3d · building SinceAug 3

Top drivers: VIX percentile ▲ S&P vs 20d avg ▲ VIX 5d momentum ▲

processId: history-market-regime

Market Indexes

Wed, Aug 5, 2026 13

S&P 500

7,723.55

+407.40

+5.57%

Dow Jones

54,349.12

+2,754.98

+5.34%

NASDAQ Composite

26,363.44

+1,920.50

+7.86%

NASDAQ 100

29,487.79

+2,295.48

+8.44%

DJ US Total Market

76,437.21

+3,936.56

+5.43%

Russell 1000

4,204.36

+217.57

+5.46%

S&P MidCap 400

3,847.33

+113.09

+3.03%

Russell 2000

3,019.19

+112.88

+3.88%

Russell 2500

1,289.31

−6.47

-0.50%

Russell 3000

4,389.55

+224.51

+5.39%

Nasdaq Financial-100

7,556.96

−17.87

-0.24%

NIFTY 50

24,624.65

+307.50

+1.26%

VIX

15.81

−1.28

-7.49%

Biggest Gainers

Wed, Aug 5, 2026 50

FWACW

Futurewave Acquisition Corporation Warrants

$0.05+$0.02

+66.7%

MGRX

Mangoceuticals, Inc. - Common StockHealthcare

$0.44+$0.25

+58.0%

NASDAQ · Mkt cap $7.2 M

Mangoceuticals surged 58% after its merger partner Nuclea Energy announced a binding MOU with Utah to develop a nuclear microreactor, signaling major regulatory and infrastructure progress toward commercialization of the Morpheus platform.

The stock's dramatic jump correlates directly with news that Nuclea Energy, Mangoceuticals' merger partner, has executed a formal memorandum of understanding with the Utah Office of Energy Development to explore a nuclear test reactor site at the Utah San Rafael Energy Lab and engage federal agencies on the Morpheus microreactor project. This represents tangible regulatory traction and site identification, moving the venture from concept toward potential construction and deployment. The prior-day announcement of a 180-day Nasdaq compliance extension (related to minimum bid price) likely provided relief that dilution or delisting risk was deferred, creating favorable conditions for the positive news to drive investor enthusiasm. For a micro-cap stock trading near penny-stock levels, news of this type—government partnership, site selection, and DOE/NRC engagement—can trigger outsized percentage gains, particularly if holders had been concerned about the company's ability to survive regulatory hurdles.

OESX

Orion Energy Systems IncIndustrials

$16.25+$5.73

+54.5%

NASDAQ · Mkt cap $76 M

Orion Energy Systems reported Q1 2027 earnings on August 5 with 32% revenue growth, record adjusted EBITDA, and a significant earnings beat (+4,800%), directly triggering the 54% stock surge.

The headline evidence is unambiguous. Orion released first-quarter results on August 5 showing revenue of $25.7 million (32% year-over-year growth), net income of $2 million, and their seventh consecutive quarter of positive adjusted EBITDA. The earnings surprise was exceptional at +4,800%, with revenue beating estimates by 10.11%. The company also emphasized strategic expansion into the hyperscale data center market and reaffirmed full-year guidance. This combination of strong operational performance, profitability return, margin expansion, and forward guidance created a clear catalyst for institutional and retail buying. No countervailing negative news is present in the headline set.

ZYBT

Zhengye Biotechnology Holding LimitedHealthcare

$2.35+$0.68

+53.6%

NASDAQ · Mkt cap $88 M

No news headlines were found in the last 48 hours for ZYBT, so the 53.59% jump cannot be directly attributed to a reported catalyst. The move likely reflects either a technical event, delayed news, or market-driven trading in a low-float biotech stock.

The complete absence of recent headlines makes it impossible to pinpoint a specific fundamental catalyst for ZYBT's dramatic gain. Biotech and small-cap stocks can experience sharp moves from several sources not yet reflected in major news feeds: delayed regulatory announcements, clinical trial results, insider transactions, analyst upgrades, or short covering in thinly traded securities. Given that ZYBT trades on NASDAQ and is ranked among the day's top four gainers, this suggests either material positive news that has not yet propagated to the RSS feeds checked, or a technical/momentum-driven move in a small-cap name. Without access to current headlines, SEC filings, or insider activity from the snapshot date itself, attribution remains speculative.

INLF

INLIF LIMITEDIndustrials

$6.29+$1.57

+41.4%

NASDAQ · Mkt cap $5.2 M

No news headlines appeared in the last 48 hours, so the 41% gain on August 5, 2026 cannot be attributed to a specific announced catalyst. The move likely reflects either delayed market reaction to an earlier announcement, technical buying, or an untracked event.

The absence of recent headlines for INLIF Limited despite a top-five daily gain makes direct attribution impossible. A 41% single-day jump is substantial and typically driven by material corporate events, but none were captured in the Yahoo Finance RSS feed provided. Potential explanations include a delayed market reaction to an announcement made more than 48 hours prior, short covering in a thinly traded small-cap security, momentum-driven technical buying following a breakout, untracked social media or forum discussion, or an off-exchange event announcement not yet reflected in major news aggregators. Without access to company releases, insider filings, or broader market data for the specific date, we cannot distinguish among these possibilities. Small-cap stocks like INLIF can be volatile and subject to information asymmetries that make same-day news capture unreliable.

JLHL

Julong Holding LimitedIndustrials

$9.18+$2.52

+41.4%

NASDAQ · Mkt cap $152 M

No news headlines were found in the last 48 hours for JLHL, so the 41.38% gain cannot be directly attributed to a disclosed catalyst. The move may reflect technical buying, short covering, or undisclosed company developments.

Yahoo Finance returned no news items for Julong Holding Limited in the 48-hour window ending August 5, 2026, which is unusual for a stock jumping to the sixth-biggest gainer of the day. Without available headlines, the cause remains unclear. Possible explanations include short squeeze activity if the stock carries meaningful short interest, technical breakout above a resistance level attracting momentum traders, delayed market reaction to an announcement not yet picked up by major news feeds, or company-specific developments reported through channels outside mainstream financial media. For small-cap or lesser-followed stocks like JLHL, news gaps are more common and moves can occur on light information or sector sentiment rather than firm company catalysts.

GTE

Gran Tierra Energy IncEnergy

$9.45+$2.70

+39.8%

NYSE · Mkt cap $357 M

Gran Tierra Energy announced a $1.33 billion sale of all its Colombian and Ecuadorian assets to Maurel & Prom on August 5, driving a 40% surge as investors rewarded the strategic repositioning and return to profitability.

The headlines establish a clear, major catalyst: Gran Tierra agreed to divest its entire South American portfolio for $1.33 billion cash consideration. The company simultaneously reported positive Q2 2026 results including net income of $25 million, adjusted EBITDA of $85 million, and positive free cash flow. Together these developments signal a strategic inflection point—the sale removes a problematic asset base while the cash infusion "fully finances" growth prospects going forward, and the Q2 results prove operational competence and profitability. News sources report the stock jumped over 45% on the announcement, consistent with the observed +39.82% close price. The late-afternoon energy sector decline noted in one headline likely reflects broader oil price weakness rather than company-specific headwinds; GTE's move in the opposite direction confirms its outperformance was driven by the asset sale and Q2 earnings, not sector momentum.

APPS

Digital Turbine IncTechnology

$13.19+$3.69

+38.8%

NASDAQ · Mkt cap $1.3 B

Digital Turbine reported fiscal Q1 2027 earnings that beat estimates, raised full-year guidance, and posted 27% revenue growth driven by AI and international expansion, triggering a 39% single-day surge and 52-week highs.

Digital Turbine released first-quarter fiscal 2027 results on August 4–5, 2026 that materially exceeded expectations and prompted management to raise full-year 2027 revenue and EBITDA guidance. The company posted $166.0 million in revenue (27% growth) and narrowed GAAP losses to $3.2 million, a near-elimination of prior losses. Headline consensus attributes gains to AI-driven momentum, international device business strength, app-growth platform performance, and advertising demand. The combination of a clean earnings beat, positive forward guidance, and management commentary on AI monetization typically catalyzes institutional rerating. The stock hit a 52-week high intraday, suggesting the earnings surprise was material enough to clear overhead resistance and trigger momentum buying.

NVA.WT

$7.55+$2.05

+37.3%

VRM

Vroom, Inc.Financial Services

$9.54+$2.48

+35.1%

NASDAQ · Mkt cap $57 M

Vroom reported its first-ever profitable quarter with positive net income and adjusted net income in Q2 2026, a major milestone for the online used-car retailer that likely drove the 35% gain.

The headline explicitly states that Vroom achieved positive net income and adjusted net income for the first time in company history during the second quarter ended June 30, 2026. This is a significant inflection point for a company that has historically operated at a loss. For a business that went public amid growth-at-any-cost investor appetite, reaching profitability represents validation of operational improvement and unit economics. The announcement was made after market close on August 4, explaining why the stock moved sharply higher on August 5. While the headline excerpt does not provide the full earnings detail (gross margins, earnings per share, revenue growth rate, or forward guidance), the profitability milestone alone is substantial enough to justify a large single-day move in a stock that trades with high volatility. The exact percentage of the move attributable to beat magnitude versus forward guidance or margin expansion cannot be determined from the headline alone.

CELZ

Creative Medical Technology Holdings, Inc.Healthcare

$0.67+$0.24

+34.9%

NASDAQ · Mkt cap $7.1 M

No news headlines were found in the last 48 hours, so the 34.91% gain cannot be attributed to any identifiable announcement or event reported by Yahoo Finance.

Creative Medical Technology Holdings is a small-cap biotech company trading at $0.67, and the absence of news in the RSS feed means this move likely stems from one of several non-headline-driven catalysts common to micro-cap stocks. Possible explanations include technical factors such as a short squeeze or algorithmic trading in a low-liquidity stock, delayed disclosure of an internal company announcement not yet picked up by major news feeds, positive clinical trial results or regulatory developments that have not yet propagated to news aggregators, or speculative buying in response to social media or message-board activity. Small-cap biomedical firms are particularly susceptible to outsized moves on thin trading volume and limited public information flow. Without access to company filings, insider transactions, or real-time trading data beyond the price action itself, it is not possible to determine which of these categories applies here.

AIEV

Thunder Power Holdings, Inc.Consumer Cyclical

$0.15+$0.04

+34.5%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours for AIEV, so the 34.55% gain cannot be attributed to any reported company announcement or market event. The move likely reflects technical trading, short-covering, or unconfirmed rumors.

The absence of any Yahoo Finance headlines in the last 48 hours is notable given the stock's strong performance today. Thunder Power Holdings is a penny stock trading at $0.15, which makes it susceptible to several common drivers of outsized moves that do not require major news: short squeezes, technical breakouts, retail trading momentum, or unconfirmed rumors circulating on message boards or social media. Penny stocks in particular often experience volatile intraday swings driven by low liquidity and speculative positioning rather than fundamental catalysts. Without access to SEC filings, press releases issued directly by the company, or trading activity data, it is impossible to pinpoint whether this was a squeeze, a technical bounce, or response to some offline information not yet covered by major financial news outlets.

BLMN

Bloomin' Brands IncConsumer Cyclical

$11.85+$2.95

+33.2%

NASDAQ · Mkt cap $831 M

Bloomin' Brands beat Q2 earnings expectations, posted positive comparable sales growth of 230 basis points, and raised full-year EPS guidance to 90 cents–$1 from 75 cents–90 cents, driven by higher check averages offsetting traffic declines.

The headlines establish a clear and unanimous narrative: Bloomin' Brands reported Q2 2026 revenue of $1.02 billion with earnings that exceeded Wall Street expectations. The company posted a significant 230 basis point comparable sales increase, marking Outback Steakhouse's strongest same-store sales performance since 2023. Most critically, management raised its full-year adjusted EPS guidance by 15 cents at the midpoint, reflecting improved restaurant margins and customer spending despite continued traffic headwinds. Multiple sources confirm diners are paying higher prices per transaction, which has more than offset the negative impact of declining customer visits and commodity inflation. This combination of a beat, positive comps, and raised forward guidance is the textbook catalyst for a restaurant stock surge, and the 33-40% move aligns directly with the magnitude of positive surprises delivered.

CLRO

ClearOne IncTechnology

$3.77+$1.32

+32.8%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours for CLRO, so the 32.75% jump lacks a clearly identified catalyst. The move may reflect technical trading, delayed news processing, or market rumors.

ClearOne Inc saw a strong single-day gain ranking it among the top 14 gainers on NASDAQ, yet no recent news headlines are available to explain the move. This disconnect suggests the catalyst is either not yet widely reported, occurred outside the 48-hour window, or is driven by non-fundamental factors. For a company in the audio and collaboration technology space, typical drivers of sharp moves include product announcements, partnership wins, quarterly earnings surprises, or changes in institutional positioning. Without headlines, the move cannot be confidently attributed to any specific event. Technical factors such as low float trading, short covering, or algorithmic momentum could also explain a 32% single-day gain in a smaller-cap stock.

PAVS

Paranovus Entertainment Technology Ltd. - Class A Ordinary SharesConsumer Defensive

$4.96+$1.60

+32.7%

NASDAQ · Mkt cap $5.5 M

No news headlines were available in the last 48 hours, so the 32.65% gain cannot be attributed to a documented announcement or event; the driver remains unknown but could include technical factors, delayed news disclosure, or speculative trading.

The absence of any news headlines in the last 48 hours means we cannot anchor the move to a specific corporate event such as earnings, product announcements, partnerships, or guidance revisions. A 32.65% single-day gain on a stock trading near $5 typically reflects either significant positive catalysts, short-covering, retail momentum, or sector-wide rallies, but without headlines we cannot confirm which. For an entertainment technology company like Paranovus, possible explanations in the absence of news might include technical chart breakouts attracting algorithmic or retail buyers, delayed disclosure of a material event not yet captured in the financial news aggregator, or participation in a broader technology or entertainment sector rally. However, these remain hypotheses rather than documented causes.

KLTR

Kaltura, Inc.Technology

$1.88+$0.46

+32.4%

NASDAQ · Mkt cap $255 M

Kaltura beat Q2 2026 earnings guidance, reported record AI-driven deal wins, and raised forward guidance, triggering a 32% rally driven by strong execution and accelerating AI commercial momentum.

The headline evidence is unambiguous. Kaltura reported second-quarter results above the high end of guidance, with record non-GAAP gross margins, subscription revenue growth, and critically, record AI-related customer wins and early commercial activity for its agentic digital experience platform. Multiple sources confirm the earnings beat and guidance raise announced on August 5. The company also introduced new real-time emotional intelligence capabilities for its AI avatars on August 4, signaling product momentum. The 32% jump is proportionate to a significant earnings beat combined with raised guidance and demonstrated product-market traction in a high-growth AI category. One offsetting note in the headlines mentions legacy segment decline and weak retention, which tempers but does not negate the overall positive narrative of AI-driven reacceleration.

MTRN

Materion CorpBasic Materials

$297.22+$69.86

+30.7%

NYSE · Mkt cap $5.0 B

Materion posted record Q2 results with double-digit growth across all segments and raised full-year EPS guidance by 30%, directly explaining the 30.72% stock surge.

Materion reported second-quarter 2026 earnings and revenue that both beat analyst estimates significantly, with earnings surprise of 22.58% and revenue surprise of 12.00%. More importantly, the company achieved record sales with all business segments posting double-digit growth. Management responded by raising full-year EPS guidance by 30%, a substantial and material upward revision that signals confidence in sustained momentum through year-end. This combination of strong operational performance, across-the-board segment growth, and elevated forward guidance directly catalyzed the 30.72% intraday gain, making Materion the 17th largest gainer on the exchange. Investors responded positively to both the beat itself and the forward-looking indication of improved profitability for the full year.

RITR

Reitar Logtech Holdings Limited Ordinary sharesIndustrials

$0.25+$0.05

+29.7%

NASDAQ · Mkt cap $4.8 M

No news headlines are available in the last 48 hours to explain the 29.71% jump in RITR stock, so the cause remains unclear without additional information about company or market developments.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for the move. RITR is a micro-cap logistics company trading at $0.25, which typically makes it sensitive to technical factors, low-volume trading dynamics, and sentiment shifts that may not generate headline coverage. The jump could stem from several plausible categories: a delayed announcement that hasn't yet appeared in the RSS feed, short covering or retail interest in a beaten-down stock, options-driven technical moves, or unconfirmed rumors circulating in small-cap trading communities. Without access to earnings releases, guidance updates, partnership announcements, or other fundamental events from the company itself, attributing the move to any specific cause would be speculative.

IGACR

Invest Green Acquisition Corporation Rights

$0.20+$0.05

+29.0%

NASDAQ

No news headlines were found in the last 48 hours, making it impossible to identify a specific catalyst for the 29% gain in IGACR, a SPAC rights offering vehicle that typically experiences volatility tied to underlying acquisition developments or merger announcements.

The absence of any news in the provided headlines is notable, yet IGACR moved 29% upward to rank among the day's biggest gainers. IGACR is a rights offering associated with Invest Green Acquisition Corporation, a SPAC structure. SPAC-related securities are prone to sharp moves driven by merger announcement timing, deal status updates, regulatory filings, or shifts in investor sentiment around the underlying business combination target. The gain could plausibly reflect positive news about a pending merger or acquisition that has not yet appeared in the Yahoo Finance RSS feed, a technical or options-driven move, or retail interest in the name. Without substantive headline coverage, the specific trigger remains unknown, though SPAC rights instruments typically respond strongly to developments in their parent entities' business combination timelines.

CDTG

CDT Environmental Technology Investment Holdings Limited ordinary sharesIndustrials

$1.49+$0.33

+28.7%

NASDAQ · Mkt cap $9.9 M

No news headlines were found in the last 48 hours, so the 28.68% gain on August 5, 2026 cannot be directly attributed to a specific announced event; the move likely reflects technical trading, sentiment shifts, or unindexed news.

CDT Environmental Technology Investment Holdings Limited gained nearly 29% on August 5 with zero news coverage in the provided 48-hour window. This disconnect between price action and disclosed information suggests the catalyst was either technical in nature, driven by retail momentum or short covering, stemming from news not captured in this RSS feed, or based on insider expectations of an upcoming announcement. Small-cap environmental technology stocks can be volatile and responsive to sector-wide sentiment shifts, commodity price moves, or regulatory environment changes that may not generate immediate formal press releases. Without access to social media, trading halts, insider filings, or delayed news sources, the specific trigger remains unidentified.

SWIM

Latham Group, Inc.Industrials

$7.30+$1.60

+28.1%

NASDAQ · Mkt cap $813 M

Latham Group beat revenue expectations in Q2 2026, raising full-year guidance on 14% net sales growth and strong demand momentum, despite missing earnings estimates and facing gross margin pressure from demand surge costs.

The headlines establish that SWIM reported Q2 earnings on August 4–5, 2026. Revenue of $197.5 million was up 14.4% year-over-year and exceeded consensus, with organic growth of 10.3% and double-digit sales growth in Sand States. The company raised its full-year guidance on the back of robust demand for fiberglass pools and related products. However, earnings per share missed estimates by 29.41%, and gross margin contracted by approximately 140–160 basis points due to incremental costs from demand surge fulfillment. The stock's 28% jump appears driven primarily by the revenue beat, guidance raise, and strong forward momentum despite the near-term margin headwind. The market has weighted the top-line acceleration and raised outlook more heavily than the earnings miss and margin compression.

FTK

Flotek Industries IncEnergy

$36.06+$7.81

+27.6%

NYSE · Mkt cap $860 M

Flotek Industries jumped 27.65% following Q2 earnings that crushed expectations with a 70% year-over-year revenue increase and a landmark $400 million Puerto Rico grid contract, combined with raised 2026 guidance.

The stock's strong move is grounded in concrete operational and financial catalysts disclosed over the past 48 hours. Q2 earnings delivered a 100% earnings surprise and 46.7% revenue surprise relative to consensus estimates. More significantly, the company announced a 10-year Puerto Rico electrical grid agreement worth $400 million in expected revenue, which represents a material backlog expansion for a mid-cap industrial firm. Management also raised full-year 2026 revenue guidance in light of year-to-date momentum and the contract win. The combination of a strong quarterly beat, major contract award, and forward guidance raise typically justifies substantial single-day appreciation, particularly for a company that appears to have been in a growth inflection phase. The 27.65% move, while significant, is proportional to the magnitude of these announcements.

SHPH

Shuttle Pharmaceuticals Holdings IncHealthcare

$4.60+$0.98

+27.3%

NASDAQ · Mkt cap $2.3 M

No news headlines were found in the last 48 hours to explain Shuttle Pharmaceuticals' 27.30% gain on August 5, 2026. The move likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or undisclosed company developments.

The absence of recent news headlines creates a gap between the magnitude of the price move and publicly reported catalysts. Shuttle Pharmaceuticals is a small-cap biotech company, and such stocks are prone to sharp intraday moves driven by several possible mechanisms: delayed market digestion of older press releases or regulatory filings not yet indexed in headline feeds, short covering in a thinly traded security, retail trading activity, options-related hedging, or unannounced developments that have not yet reached public news services. Without access to intraday volume data, insider trading reports, FDA submissions, clinical trial announcements, or financial results released on or shortly before August 5, it is not possible to pinpoint the specific catalyst with confidence. The timing lag between company disclosures and news aggregation can obscure causality, especially for smaller-cap securities with lower analyst coverage.

ZTG

Zenta Group Company LimitedIndustrials

$6.76+$1.45

+27.2%

NASDAQ · Mkt cap $30 M

No news headlines were published in the last 48 hours for ZTG, so the 27% gain cannot be traced to a disclosed catalyst. The move likely reflects technical trading, delayed news dissemination, or market rumors not yet captured by the news feed.

The absence of recent headlines despite a significant single-day rally is notable and limits our ability to identify a specific fundamental cause. For a microcap or less-widely-covered stock like ZTG, plausible drivers of a 27% move without news include: (1) technical reversal or short covering after a period of weakness, (2) a news release or earnings announcement that has not yet been picked up by the Yahoo Finance RSS feed or other public sources, or (3) retail or algorithmic trading activity responding to price action itself. Without access to company filings, earnings calendars, or real-time alert systems, we cannot rule out that meaningful news did drop but simply is not visible in this snapshot.

TGE.WT

The Generation Essentials Group

$0.18+$0.04

+26.0%

NYSE

No news headlines were published in the last 48 hours, so the 26% gain on TGE.WT lacks an identifiable catalyst from publicly reported sources. The move may reflect technical factors, delayed news dissemination, or retail activity in a low-priced warrant security.

The absence of any recent headlines makes direct attribution impossible. TGE.WT is a warrant (a leveraged derivative security), which typically exhibits higher volatility and can attract retail traders and technical traders seeking outsized daily moves. Warrant prices are sensitive to moves in the underlying stock, implied volatility, and time decay, so even a modest move in Generation Essentials' common shares could amplify into a 26% warrant gain. Without news, the catalyst could be a delayed earnings report, an announcement not yet picked up by Yahoo Finance's RSS feed, technical breakout buying, short covering in a thinly traded security, or broader sector rotation. None of these can be confirmed from the evidence at hand.

CSAI

Cloudastructure, Inc. Class A Common StockTechnology

$5.00+$1.03

+25.9%

NASDAQ · Mkt cap $4.5 M

Cloudastructure announced a third deployment with a major luxury multifamily operator in Houston, expanding its presence to 38% of that client's portfolio, which likely drove the 25.94% gain on revenue growth and market expansion visibility.

The headline from August 4, 2026 describes a concrete business expansion: Cloudastructure secured its third deployment with a significant real estate operator, now covering more than one-third of that client's Texas portfolio. This indicates revenue traction, customer confidence through repeat deployment, and geographic footprint growth in a material market. For a smaller-cap technology or infrastructure services company trading at $5.00, tangible contract wins that demonstrate customer stickiness and portfolio depth typically attract investor interest, especially if the deal size or implied value is material enough to move growth expectations. The 26% single-day move is consistent with a positive operational update that validates the business model and reduces execution risk for investors.

ASTC

Astrotech CorpTechnology

$9.07+$1.83

+25.4%

NASDAQ · Mkt cap $16 M

No news headlines were found in the last 48 hours to explain ASTC's 25.42% gain on August 5, 2026, so the catalyst remains unclear without additional information.

A 25% single-day jump with zero identified news in the prior 48 hours is striking and suggests either a delayed disclosure, an intraday announcement not yet captured in the RSS feed, or a non-news catalyst. Astrotech Corp is a small-cap technology and space-related company historically prone to volatility and retail interest. Possible explanations include a contract award or partnership announcement made after the news cutoff, short covering if the stock had heavy short interest, technical reversal after a downtrend, or insider buying that markets reacted to. Without the specific news trigger, attribution is speculative. The absence of headlines despite a top-27 ranking move is unusual and suggests checking the company's investor relations page or SEC filings for same-day announcements would be necessary to confirm the actual driver.

SMRT

Stein Mart IncTechnology

$1.30+$0.26

+25.0%

NYSE · Mkt cap $266 M

SmartRent beat Q2 2026 revenue expectations with $39.84 million in sales (up 4% year-over-year) and in-line earnings, triggering a 25% rally as the market repriced the stock on positive earnings surprise.

SmartRent reported second-quarter 2026 results on August 5, 2026, that exceeded consensus revenue expectations. The company delivered $39.84 million in sales, representing 4% year-over-year growth, while posting a GAAP loss of $0.03 per share that matched analyst forecasts. For a micro-cap stock trading at $1.30, an earnings beat—even a modest one in absolute terms—can trigger outsized percentage moves, particularly if the stock had been depressed or if investors had low expectations embedded in the valuation. The combination of revenue outperformance plus meeting profitability guidance likely reassured the market on the company's trajectory and operational execution, driving the 25% intraday gain.

AMWL

American Well CorpHealthcare

$12.98+$2.55

+24.4%

NYSE · Mkt cap $211 M

American Well reported Q2 earnings on Aug 4–5 with a major government contract win and narrowed EBITDA losses despite a 26.6% revenue decline, beating revenue estimates and triggering a 24.45% stock surge.

The earnings release from Aug 4–5 establishes that AMWL beat revenue expectations by 3.84% and delivered a positive earnings surprise of 1.67%, though absolute revenue fell to $52 million year-over-year. The headlines emphasize two concrete achievements: narrowed adjusted EBITDA losses and a significant government contract win with the Department of Health and Human Services (DHA reference). The company also raised full-year profitability guidance. For a healthcare SaaS platform that has been under pressure, simultaneous evidence of cost discipline (narrowing losses), major contract capture, and improved forward guidance are typically sufficient to attract mean-reversion and relief buying. The steep intraday rally suggests investors had positioned for worse outcomes or that the DHA contract represents a material new revenue stream or credibility inflection.

SITM

SiTime CorpTechnology

$543.78+$141.00

+24.1%

NASDAQ · Mkt cap $18 B

SiTime reported Q2 2026 net revenue of $157.4 million, up 127% year-over-year, which directly triggered the +24% stock surge as a major earnings beat exceeded likely expectations for the precision timing chipmaker.

The headline confirms SiTime announced Q2 2026 financial results on 2026-08-05, the exact date of the stock's jump. Net revenue increased 127% to $157.4 million, representing exceptional top-line growth. For a semiconductor company in the precision timing space, a revenue surge of this magnitude signals strong demand, likely driven by adoption in data centers, telecommunications, or automotive applications where timing components are critical. While the full earnings release summary is truncated in the RSS feed, the 127% revenue growth alone is material enough to justify a 24% stock move, as it far exceeds typical semiconductor industry growth rates and suggests SiTime is winning significant market share. The fact that this announcement dropped during market hours on the same day as the price move confirms temporal causality. Earnings surprises of this magnitude, especially in growth-focused semiconductor subsectors, routinely drive double-digit percentage moves.

ALTI

Cartesian Growth CorporationFinancial Services

$4.62+$0.90

+24.0%

NASDAQ · Mkt cap $607 M

Cartesian Growth Corporation (ALTI) jumped 24% on August 5th likely in anticipation of or reaction to second quarter 2026 financial results announced on August 3rd, though the headline only confirms the announcement date and does not reveal actual results or guidance.

The single headline provided announces that AlTi Global will release Q2 2026 financial results but does not disclose the actual earnings, revenue, guidance, or any performance metrics. The timing is suggestive: the announcement came August 3rd and the stock spiked August 5th, consistent with market reaction to reported results. However, without access to the actual earnings release or consensus expectations, it is impossible to determine whether results beat, missed, or met expectations. The stock trades as a wealth manager with approximately $90 billion in assets under management, a sector sensitive to market performance, AUM growth, and fee dynamics. The move could reflect positive earnings surprise, upside guidance, AUM growth, or market sentiment shift favoring asset managers. Alternatively, the timing could be coincidental and the move driven by sector rotation, technical factors, or unrelated news not captured in the provided headlines.

ANTA

Antalpha Platform Holding CompanyFinancial Services

$3.91+$0.75

+23.7%

NASDAQ · Mkt cap $93 M

No news headlines were found in the last 48 hours, so the 23.71% gain on ANTA appears driven by factors other than disclosed corporate announcements; technical trading or market rumors are the most likely culprits.

The absence of any recent news headlines in the provided RSS feed makes it impossible to identify a specific catalyst for ANTA's strong 23.71% intraday gain. This stock is a micro-cap Chinese fintech platform, a sector historically prone to volatility driven by technical factors, short covering, or undisclosed news that may not immediately appear in mainstream financial feeds. The jump into the top 32 daily gainers suggests either coordinated retail buying interest, a short squeeze on a thinly traded name, or an announcement that has not yet propagated through the RSS sources checked. Without access to real-time social media, chat forums, or official company filings released in the last 48 hours, the precise driver remains opaque.

CTXR

Citius Pharmaceuticals IncHealthcare

$0.78+$0.15

+23.3%

FLZH

Flash Sports & Media Holdings, Inc.Communication Services

$1.43+$0.27

+23.2%

NASDAQ · Mkt cap $60 M

Flash Sports & Media announced a term sheet to acquire 51% of Bongo, gaining access to 300M viewers and ~$10M in revenue while being EBITDA accretive, driving the 23% stock jump on August 5.

On August 5, 2026, Flash Sports & Media Holdings announced a significant acquisition milestone: a term sheet to acquire a 51% stake in Bongo. The deal provides immediate access to an audience of 300 million viewers and approximately $10 million in revenue, with the company explicitly stating the transaction is EBITDA accretive from the outset. For a micro-cap stock trading at $1.43, this represents a material strategic expansion that directly adds viewership scale and near-term profitability. The announcement came during market hours, explaining the same-day 23% rally. No competing news or contradictory information appears in the recent headlines, making this the clear catalyst for the move.

PRGO

Perrigo Co PLCIndustrials

$13.27+$2.48

+23.0%

NYSE · Mkt cap $2.0 B

Perrigo surpassed Q2 earnings estimates by 61.29% and revenue by 1.89%, driving a 23% single-day gain despite a 3.1% core sales decline. The earnings beat appears to be the primary catalyst.

Perrigo announced second-quarter 2026 results on August 5, 2026, with a substantial earnings surprise of 61.29% above consensus expectations. This beats-driven rally is the most straightforward explanation for the 22.98% jump. The company also reported revenue that beat estimates by 1.89%. The earnings call highlights note the company achieved strategic market share gains in infant formula and innovation initiatives, partially offsetting a 3.1% decline in core net sales. The magnitude of the earnings beat—more than 60%—is substantial enough to justify meaningful positive repricing, particularly if the market had low expectations heading into the announcement. The sales decline is a headwind, but the earnings quality and beat clearly dominated the market's initial reaction.

CRCT

Cricut, Inc.Technology

$6.07+$1.13

+23.0%

NASDAQ · Mkt cap $1.2 B

Cricut's 22.96% surge was driven by a massive earnings beat of 375% on the bottom line combined with record subscriber growth and strong profitability gains, offsetting a 9% revenue decline attributable to tariff headwinds.

Cricut reported Q2 2026 earnings that significantly exceeded expectations, with net income jumping 59% year-over-year to $39.1 million despite revenue declining 9% to $156.3 million. The earnings surprise of 375% indicates the street had expected a much smaller profit or a loss. Management highlighted platform revenue growth of 5% and record paid subscriber growth to 3.1 million, signaling that the company's shift toward recurring subscription revenue is offsetting one-time product sales weakness. The tariff-related headwinds are portrayed as temporary comparison effects, and the company's strong cash generation plus a recurring dividend reinforce financial stability. For a company that has faced challenges, demonstrating margin expansion and subscriber momentum despite topline pressure appears to have been a sufficient surprise to drive significant short-covering or positive reassessment.

GSM

Ferroglobe PLCBasic Materials

$4.14+$0.74

+21.8%

NASDAQ · Mkt cap $757 M

Ferroglobe reported strong Q2 2026 results on August 4 with higher shipments, revenue, adjusted EBITDA of $13.1 million, and improved free cash flow, driving a 21.80% gain as the market rewarded operational improvements and stronger cash generation.

The earnings release on August 4 highlighted several positive operational metrics that likely triggered the 21.80% jump. Ferroglobe demonstrated sequential shipment growth driven by increased silicon metal volumes in key markets, reporting $13.1 million in adjusted EBITDA and higher free cash flow. The company also ended the quarter with $93 million in total cash, suggesting improved liquidity. For a commodity producer like Ferroglobe, sequential improvements in shipment volumes, fixed-cost absorption, and cash generation are material positive signals that the company is navigating a challenging cyclical environment effectively. The August 5 earnings call highlights appear to have amplified the market's positive reception. Given GSM's commodity-exposed profile, investors were likely pleased by evidence of volume growth and operational leverage translating to bottom-line improvement.

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary SharesHealthcare

$3.56+$0.63

+21.5%

NASDAQ · Mkt cap $8.0 M

No headlines were found in the last 48 hours to explain the 21.50% gain in CUPR stock, so the catalyst remains unknown; the move may reflect technical trading, delayed news pickup, or market speculation.

Cuprina Holdings (Cayman) Limited is a relatively low-priced NASDAQ-listed stock that moved sharply upward with no corresponding news coverage in the prior 48 hours according to available feeds. This gap between price action and news visibility is common in smaller-cap or thinly traded securities. Possible explanations include a delayed news announcement not yet picked up by major RSS feeds, technical momentum from oversold conditions, short covering, or sector-wide movement in a related industry. Without access to company filings, insider transactions, or broader market catalogs, specific identification of the catalyst is not possible. The stock's positioning as a micro-cap international holding company offers limited structural insight into whether the move reflects fundamentals or liquidity-driven trading.

USDE

StablecoinX Inc.Financial Services

$2.45+$0.42

+21.4%

NASDAQ · Mkt cap $74 M

No relevant news was published in the last 48 hours, so the 21.44% gain likely stems from technical factors, market rumors, or delayed announcements not yet captured in major news feeds.

No headlines were found in the last 48 hours that would explain USDE's sharp 21.44% jump. For a stablecoin-related company, typical catalysts include announcements of regulatory approval, partnerships with major exchanges or financial institutions, integration into new platforms, or expansion of use cases. It's also possible the move reflects a delayed market reaction to news published earlier than the 48-hour window, or trading driven by technical factors such as short covering, algorithmic buying at support levels, or social media-driven retail interest. Stablecoin stocks can be volatile on sentiment shifts around regulatory clarity or adoption metrics. Without contemporaneous headlines, the root cause remains unclear.

WYTC

WYTEC INTERNATIONAL INC

$1.70+$0.30

+21.4%

NASDAQ

No news headlines were found in the last 48 hours, so the 21.43% gain likely reflects technical trading activity, delayed news dissemination, or unconfirmed market chatter rather than a confirmed company announcement.

The absence of any news coverage in the Yahoo Finance RSS feed for WYTEC International in the last 48 hours makes it difficult to pinpoint a specific catalyst for the jump to 40 among daily gainers. For a micro-cap stock trading near $1.70, typical drivers of sharp single-day moves without immediate headline coverage include short covering or technical momentum plays, which are common in lower-liquidity securities. Alternatively, the company may have issued a press release that has not yet been indexed by major news aggregators, or there may be unconfirmed market chatter driving retail interest. Without corroborating news, attributing the move to fundamentals would be speculative.

MOBQ

Mobiquity Technologies, Inc.Communication Services

$0.74+$0.13

+21.3%

NASDAQ · Mkt cap $19 M

No news headlines were found in the last 48 hours, so the 21.31% gain on MOBQ likely stems from technical trading activity, delayed announcements, or market rumors rather than a confirmed corporate event.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for today's 21.31% jump in MOBQ stock price. Mobiquity Technologies is a micro-cap stock trading at $0.74, which typically exhibits higher volatility and can be more sensitive to technical factors, short covering, or retail trading activity than larger-cap securities. Common drivers for penny stocks in the absence of disclosed news include improved technical momentum, covering of short positions, speculative buying based on unconfirmed rumors or social media discussion, or delayed announcement of quarterly results. Without concrete evidence of a corporate development, the move remains unexplained by the available information.

SORA

Top Win International LimitedConsumer Cyclical

$2.40+$0.42

+21.2%

NASDAQ · Mkt cap $57 M

No news headlines were found in the last 48 hours for SORA, so the 21% gain likely reflects either delayed reporting of an announcement, technical buying, or a rumor not yet captured in major financial media.

The absence of any headlines in the last 48 hours makes it impossible to anchor the 21% jump to a specific catalyst. For a small-cap stock like Top Win International, typical drivers of large single-day moves include earnings surprises (positive or negative), insider transactions, analyst upgrades or downgrades, merger or acquisition news, regulatory developments, or shifts in business fundamentals. It is also possible the move reflects technical factors such as short covering, options expiration dynamics, or retail interest. Without corroborating news, the most honest assessment is that either a material announcement has not yet been picked up by the RSS feed, or the move is driven by sentiment, technicals, or information not yet public. The gap between the stock's ranking as the 42nd biggest gainer and the complete absence of reported news is notable and suggests the headline lag may be real.

GERN

Geron CorpHealthcare

$1.63+$0.28

+20.8%

NASDAQ · Mkt cap $970 M

Geron reported Q2 2026 earnings on August 5th with 17% year-over-year revenue growth to $57.5 million, raised full-year guidance, and progressed regulatory discussions for its IMPACT MF trial, driving the +20.82% gain.

Geron's earnings release delivered multiple positive catalysts on the same day. The company reported net revenue of $57.5 million in Q2 2026, representing 17% year-over-year growth and 11% sequential growth, indicating expanding uptake of RYTELO (imetelstat) in the lower-risk myelodysplastic syndrome market. The headline "Geron Reports Q2 Loss, Beats Revenue Estimates" shows the company exceeded analyst revenue expectations by 4.49%. Most significantly, management raised full-year 2026 guidance and announced progress on regulatory discussions related to the IMPACT MF trial, which would represent a material clinical expansion. For a biotech company trading at this price point, revenue growth acceleration, guidance raises, and advancing clinical trials typically trigger substantial single-day rallies. The combination of better-than-expected commercial execution and pipeline advancement explains the outsized daily move.

ONCO

Onconetix, Inc.Healthcare

$1.00+$0.17

+20.8%

NASDAQ · Mkt cap $2.8 M

Onconetix announced the appointment of Ralph Schiess, PhD to the board of its subsidiary Proteomedix AG and the re-election of Thomas Meier as chairman, likely driving investor confidence in the company's oncology platform and leadership structure.

The headline published on August 5, 2026 at 12:30 UTC—the same day as the stock's 20.76% jump—reports a board appointment and leadership re-election at Proteomedix AG, a company in which Onconetix holds interest. Schiess is identified as a Proteomedix co-founder and co-developer of Proclarix, suggesting deep technical expertise being returned to the board. The timing of the announcement aligns closely with the intraday move. However, the full press release text is truncated in the provided excerpt, so the complete context and any other strategic details that may have motivated investor buying are not visible. Board appointments and leadership continuity typically signal confidence in governance and product development trajectory, which can drive small-cap biotech stock appreciation.

WTTR

Select Energy Services IncEnergy

$22.28+$3.78

+20.4%

NYSE · Mkt cap $2.9 B

Select Water Solutions (WTTR) jumped 20.43% after reporting Q2 earnings that beat revenue expectations by 8.17% and earnings by 54.55%, with profits nearly doubling year-over-year.

The stock's sharp gain is directly tied to strong second-quarter financial results announced on August 4-5, 2026. Multiple headlines confirm that WTTR delivered a significant earnings surprise (54.55% above estimates) and topped revenue guidance, posting sales of $395.8 million, up 8.7% year-over-year with GAAP profit of $0.17 per share that was 78.9% higher than the prior year. The company is an oilfield water management and sustainable water and chemical solutions provider, a sector that benefits from activity in energy production. The magnitude of the earnings beat relative to expectations, combined with the narrative of "strong demand for its services," appears to have driven the outsized 20.43% intraday gain, lifting the stock to an all-time high. The consistency of the beat across both revenue and bottom-line metrics suggests genuine operational strength rather than a one-time anomaly.

TBI

TrueBlue IncIndustrials

$9.91+$1.68

+20.4%

NYSE · Mkt cap $330 M

TrueBlue delivered a significant earnings beat with 160% EPS surprise and 12% revenue growth across all segments, triggering the 20% stock jump on positive forward momentum despite a non-cash writedown headwind.

The headlines establish that TrueBlue reported Q2 2026 results on August 4th with a substantial 160% earnings surprise and 6.45% revenue beat relative to consensus expectations. The company achieved 12% year-over-year revenue growth with all business segments showing expanded profitability, which represents solid operational execution. While the earnings report notes gross margin headwinds and a non-cash writedown that produced a net loss, these appear to be one-time or structural items that did not prevent the bottom-line beat. The combination of material EPS upside, broad-based segment growth, and positive earnings momentum typically drives 20%+ single-day gains in smaller-cap stocks, particularly if investors had been positioned defensively or underweight heading into the print.

SMJF

SMJ International Holdings Inc.Consumer Cyclical

$6.82+$1.18

+20.3%

NYSE · Mkt cap $297 M

No headlines were published in the last 48 hours for SMJF, so the 20.34% gain cannot be directly attributed to disclosed news. The move likely reflects technical trading, short covering, or undisclosed catalyst.

SMJF jumped 20.34% to rank 47 among daily gainers on 2026-08-05, but Yahoo Finance returned zero headlines in the prior 48 hours. This disconnect between a substantial single-day rally and the absence of public news is notable. For a stock at this price point and apparent trading volume, such a move typically stems from one of several categories: short squeeze or covering activity if the stock has high short interest, technical momentum breaking through a resistance level, rumored corporate action not yet publicly announced, insider buying signals, or a delayed market reaction to a previously issued release. Without access to earnings calendars, company filings, or real-time social media discussion, we cannot distinguish among these possibilities. The stock's small-cap profile (suggested by the name and price) may amplify volatility from modest share volume shifts.

SBEV

Splash Beverage Group, Inc.Consumer Defensive

$0.42+$0.07

+19.9%

NYSE · Mkt cap $2.5 M

Splash Beverage announced a partnership with Lupvindol Biosciences to advance CannEpil, a cannabinoid treatment for pet oncology and chronic pain, likely triggering the 19.87% gain by signaling progress in a high-potential veterinary drug pipeline while retaining IP and commercialization rights.

The headline establishes a concrete partnership announcement between Splash Beverage and Lupvindol Biosciences focused on advancing CannEpil through the FDA veterinary pathway. The deal grants Splash ownership of resulting data, intellectual property, and commercialization rights, which is a material advantage. For a micro-cap stock trading at $0.42, any substantive veterinary pharmaceutical development news can trigger outsized moves, especially when it involves FDA pathway clarity and IP retention. The announcement directly addresses two growing markets: companion-animal healthcare and cannabinoid therapeutics. However, the headline does not disclose valuation details, funding terms, or development timelines, limiting assessment of the partnership's true economic significance. The move ranks 48th among daily gainers, suggesting moderate institutional attention rather than massive volume.

LESL

Leslie''s IncConsumer Cyclical

$1.34+$0.25

+19.5%

NASDAQ · Mkt cap $6.1 M

Leslie's stock surged 19.53% on August 5, 2026, the day it announced third-quarter earnings results will be reported on August 12, 2026. No specific financial results or guidance were disclosed in the announcement itself, making the cause unclear from available headlines.

The only news provided is a routine earnings announcement stating that Leslie's will report Q3 2026 results on August 12, 2026. This is a standard procedural disclosure, not a material event like a beat, miss, guidance raise, or strategic announcement. The timing suggests the market may have reacted to anticipation of results, a short squeeze on a depressed stock price of $1.34, or the announcement of an earnings date itself in a stock that had been beaten down. Pool and spa care retail stocks are cyclical and sensitive to seasonal demand, so positive summer demand signals in industry commentary could theoretically drive sentiment, but no such evidence appears in the headlines. Without actual financial results, guidance changes, or other substantive news, the driver remains speculative.

MBAI

Check-Cap Ltd.Healthcare

$1.29+$0.20

+18.3%

NASDAQ · Mkt cap $11 M

Check-Cap Ltd. announced it has filed its Form F-1 and expects its merger with MBody AI Corp. to close within eight weeks, likely triggering the 18.35% intraday gain as investors view merger closure as increasingly concrete.

The headline directly addresses a material corporate event: Check-Cap's public filing of Form F-1 and a narrowed timeline for merger completion with MBody AI Corp. This represents forward progress on an announced transaction, moving from earlier uncertainty toward a defined eight-week closure window. For a small-cap biotech or medical device company trading near $1.29, clarity on merger timing and regulatory filing completion is typically a significant positive catalyst. Investors interpreting this as de-risking the transaction or signaling regulatory acceptance would naturally bid the stock higher. The ranking as the 50th biggest gainer suggests broad market participation in the move, consistent with a headline-driven event rather than isolated accumulation.

Biggest Losers

Wed, Aug 5, 2026 50

RCON

Recon Technology LtdEnergy

$0.06−$0.35

-84.7%

NASDAQ · Mkt cap $1.7 M

RCON fell 84.68% with no material news reported in the last 48 hours, making the catalyst unclear; the drop likely reflects either a delayed negative announcement, technical forced selling, or a micro-cap volatility event unrelated to recent headlines.

No headlines were found in the Yahoo Finance RSS feed for the last 48 hours surrounding this crash. This absence of news is itself significant given the magnitude of the move. RCON is a micro-cap stock trading at $0.06, a category highly susceptible to volatility from several sources that may not generate formal press coverage: sudden delisting warnings, regulatory compliance failures, reverse splits, shareholder disputes, or forced liquidation from institutional holders. The stock could also have experienced a sharp technical breakdown from oversold conditions or margin calls. Without a specific news anchor, the true catalyst remains unknown, though the sheer magnitude suggests either an undisclosed company-level event or severe technical/liquidity dysfunction rather than a random market fluctuation.

SXTC

China SXT Pharmaceuticals IncHealthcare

$0.07−$0.06

-47.5%

NASDAQ · Mkt cap $2.4 M

China SXT Pharmaceuticals announced a share consolidation on August 5, which likely triggered the 47% single-day drop as investors reacted to the dilutive capital structure event.

The company announced a share consolidation of its Class A ordinary shares effective today. Share consolidations typically signal financial distress or an attempt to reverse a steep stock decline by reducing share count while maintaining total market capitalization; however, they are often perceived negatively by the market because they suggest prior underperformance and can be followed by dilution or further adverse actions. The stock's position as the second-largest loser on the day coinciding with this announcement suggests the market viewed the consolidation unfavorably. Without the full text of the announcement specifying the consolidation ratio, reverse split multiplier, or stated rationale, we cannot determine whether this was a 1-for-10, 1-for-100, or other ratio, but the timing correlation is clear. The substantial single-day drop indicates acute negative sentiment toward this restructuring move.

SPPL

SIMPPLE LTD. - Ordinary SharesIndustrials

$2.00−$1.54

-43.5%

NASDAQ · Mkt cap $22 M

SPPL dropped 43.48% on August 5, 2026, but no news headlines were found in the prior 48 hours to explain the move, leaving the specific catalyst unknown.

The absence of any news headlines in the last 48 hours makes it difficult to pinpoint a definitive cause for this sharp 43.48% decline, which ranks SPPL as the third biggest loser of the day. For a microcap or small-cap stock like SPPL trading at $2.00, typical catalysts for such large single-day moves include earnings disappointments, insider selling, clinical trial failures or regulatory setbacks if biotech-related, sudden liquidity concerns, short squeezes unwinding, or delayed negative announcements that may not yet be reflected in major news feeds. The gap between price action and available news headlines suggests either that the triggering event has not yet been widely reported, occurred before the 48-hour window, or that the stock was subject to technical selling or broker downgrades not yet captured in public headlines. Without access to company filings, insider transactions, or real-time regulatory announcements, the root cause remains speculative.

SUJA

Suja Life, Inc.Consumer Defensive

$6.13−$4.70

-42.7%

NASDAQ · Mkt cap $176 M

Suja Life reported strong Q2 earnings with 11.6% revenue growth and 50% EBITDA growth on August 4th, yet the stock crashed 42.7% the next day, suggesting the market either reacted negatively to forward guidance, channel headwinds flagged for Q3, or an unrelated catalyst outside the provided headl…

The earnings headlines from August 4-5 paint a picture of solid operational performance: net sales up 11.6% to $83.9 million, adjusted EBITDA surging 50%, and gross profit growth of 9.9%. Management reaffirmed full-year profitability guidance and noted strong demand for cold-pressed juices and wellness shots. However, the same headlines explicitly mention softer recent bookings in grocery channels and Q3 headwinds, which could have disappointed growth-focused investors despite the strong Q2 beat. Additionally, Paine Schwartz Partners announced an intention to purchase shares on August 4th, which is neutral-to-positive signaling. The magnitude of the 42.7% drop is unusually severe relative to typical earnings volatility and suggests either a significant guidance cut, a massive miss on some metric not captured in these headlines, or an entirely separate catalyst (insider selling, margin call, sector rotation, or market-wide event) that these summaries do not cover.

VSEE

VSee Health, Inc.Healthcare

$0.05−$0.04

-42.0%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 42% decline cannot be directly attributed to a specific announcement; the move likely reflects sector pressure, technical selling, or undisclosed corporate developments.

VSee Health is a telemedicine and healthcare technology company, and a 42% single-day drop with zero news coverage in the preceding 48 hours is unusual but not unprecedented for micro-cap healthcare stocks. The absence of headlines does not mean no catalyst occurred—it may indicate that news was not yet picked up by major financial RSS feeds, or that the market is reacting to delayed information, technical breakdown below support levels, or broader sector weakness in telehealth stocks. Micro-cap healthcare equities are also sensitive to changes in funding outlook, clinical trial setbacks, or regulatory headwinds that may circulate via press release or investor relations channels before reaching mainstream coverage. Without visible news, the most likely categories are technical breakdown, undisclosed corporate news, or sector rotation out of telehealth names.

MYSEW

MYSEWTechnology

$0.02−$0.01

-39.7%

NASDAQ

No news headlines are available in the last 48 hours to explain the 39.71% drop in MYSEW, so the cause remains unknown; this is typical for micro-cap stocks where trading can be volatile and driven by undisclosed events or technical factors.

Zero news headlines were found in the last 48 hours despite MYSEW ranking as the sixth biggest loser on NASDAQ on August 5, 2026. At a price of $0.02, this is a micro-cap security where volume constraints, limited analyst coverage, and reduced information flow are structural norms. Stocks in this category can experience sharp daily swings from several sources: a delayed earnings miss or guidance warning that has not yet been widely reported, insider selling or lock-up expiry events, delisting warnings from the exchange, short-seller reports, or purely technical selling in low-liquidity conditions. Without specific news or access to company filings or insider transactions on the snapshot date, attribution is speculative. The absence of any headline coverage within 48 hours of a 40% drop is itself noteworthy and suggests either that the event triggering the move has not yet reached mainstream financial media, or that the stock trades in such low volumes that major news outlets do not track it closely.

TYGO

Tigo Energy IncTechnology

$1.29−$0.77

-37.4%

NASDAQ · Mkt cap $88 M

Tigo Energy reported Q2 2026 earnings that missed internal expectations with only 5.6% revenue growth, revised guidance downward, and delayed product launches amid softer residential solar markets, triggering the 37% sell-off.

The earnings headlines establish that Tigo faced a materially disappointing quarter despite modest year-over-year revenue growth of 5.6%. The company explicitly noted results fell below its own expectations, cited softer residential solar market conditions, and disclosed delays in launching a key product. Management revised guidance downward going forward. While the headlines mention "regulatory tailwinds" and confidence in Q4 ramp, these forward-looking statements were apparently insufficient to offset the combination of near-term misses and reduced near-term visibility. For a small-cap energy equipment company, a significant earnings miss coupled with guidance cuts and execution delays typically triggers sharp repricing, especially if investors had positioned for acceleration in the solar market.

LMB

Limbach Holdings IncIndustrials

$49.50−$27.46

-35.7%

NASDAQ · Mkt cap $594 M

Limbach missed Q2 revenue estimates, reported a -34.69% earnings surprise, faced margin pressure and healthcare/institutional market softness, and lowered full-year adjusted EBITDA guidance, causing the 35.68% drop on August 5th following an initial 10.1% decline on August 4th.

The stock fell sharply over two trading days following Limbach's Q2 2026 earnings release on August 4th. While the company posted 21.9% year-over-year sales growth to $173.5 million, it missed Wall Street's revenue expectations and delivered a significantly worse earnings surprise of -34.69%. Management attributed underperformance to project timing delays, softness in healthcare and institutional markets, and margin compression. Most critically, the company lowered its adjusted EBITDA guidance for full-year 2026, which typically signals management's loss of confidence in future profitability and cash generation. Although Limbach announced a strategic CYMCOR acquisition to strengthen its data center services platform and reported robust bookings, the combination of missed estimates, margin headwinds, and reduced forward guidance overwhelmed any positive sentiment from the acquisition news, explaining the continued heavy selling through August 5th.

SZZL

Sizzle Acquisition Corp.Financial Services

$6.68−$3.70

-35.6%

NASDAQ · Mkt cap $327 M

No news headlines were reported in the last 48 hours, so the 35.65% drop cannot be attributed to a disclosed catalyst; the decline likely reflects technical selling, a delayed announcement, or sector-specific pressures affecting blank-check companies.

The absence of any recent news headlines makes direct attribution of this severe single-day loss impossible. SZZL is a SPAC (special purpose acquisition company), a security class historically sensitive to interest-rate expectations, redemption risk, and deal uncertainty. Large single-day declines in SPACs without accompanying news often stem from technical factors such as options expiration, margin-call driven selling, or a delayed announcement that has not yet been picked up by major news feeds. Alternatively, the decline could reflect a negative development disclosed through other channels not captured in the Yahoo Finance RSS feed, or pressure from the broader SPAC sector or equities market. Without corroborating headlines or structural detail, the specific cause remains speculative.

USNA

USANA Health Sciences IncConsumer Defensive

$15.04−$7.76

-34.0%

NYSE · Mkt cap $245 M

USANA reported a Q2 2026 loss with revenue missing estimates by nearly 5%, triggering a sharp 34% decline as the stock reacted to both earnings disappointment and underlying business weakness.

USANA disclosed second-quarter 2026 results on August 4 that included a reported net loss and revenue that fell 5.4% year-over-year to $223 million, missing consensus expectations by approximately 5%. The earnings surprise registered at -116.28%, indicating the company swung to a loss when a profit was anticipated. The initial market reaction was a 19.2% drop on August 4, but the stock fell an additional 15% by August 5, suggesting either broader deterioration in guidance, margin compression details, or continued selling pressure as news spread. The August 5 headline about the CEO promoting workplace happiness appears unrelated to the price action and was likely published before or after the earnings decline. The combination of declining year-over-year sales, an unexpected loss, and a miss on top-line expectations represents a material negative surprise for a health and wellness company already facing competitive pressures in the nutrition sector.

FLNC

Fluence Energy, Inc.Utilities

$14.37−$5.33

-33.7%

NASDAQ · Mkt cap $1.9 B

Fluence Energy missed Q2 2026 sales expectations, triggering a 27% initial drop that widened to 33.69% by day's end, likely compounded by broader weakness in energy storage and solar sector stocks.

Fluence reported Q2 CY2026 results on August 5, missing Wall Street revenue expectations despite posting 7.9% year-over-year sales growth to $649.8 million. The headline explicitly notes a 27.1% stock drop tied to this miss. The additional 6-7 percentage point decline to the final -33.69% close may reflect broader sector contagion: a separate headline from the same day reports that SolarEdge posted a weak Q3 outlook, causing solar stocks to tumble. Since Fluence operates in the energy storage and grid optimization space, overlapping with renewable and solar infrastructure demand drivers, the sector-wide selloff likely amplified the earnings-driven decline. No guidance suspension or major restructuring was announced in the available headlines, so the miss appears to be a revenue shortfall rather than a fundamental business deterioration.

DBGI

Digital Brands Group, Inc.Consumer Cyclical

$16.03−$7.41

-31.4%

NASDAQ · Mkt cap $6.8 M

Digital Brands Group announced receipt of a $77.58 per share all-cash acquisition proposal on August 5, yet the stock fell 31.4%, suggesting investor skepticism about deal certainty, valuation adequacy, or execution risk.

The headline confirms that DBGI received an all-cash proposal at $77.58 per share. The stock's closing price of $16.03 is dramatically below that stated offer price, which is counterintuitive on its face. This discrepancy points to several possible explanations: the deal may face regulatory or financing uncertainty, there may be competing bids or a superior proposal already in play, the market may doubt the bidder's credibility or ability to close, or shareholders may view the offer as inadequate relative to standalone prospects. The 31.4% drop suggests the market is pricing in material doubt that the deal will consummate at the announced terms, or that a better offer is coming. Without the full press release text, we cannot determine whether conditions, timing, or bid structure create obvious risk factors.

ZJYL

JIN MEDICAL INTERNATIONAL LTD. - Ordinary SharesHealthcare

$2.22−$0.99

-31.2%

NASDAQ · Mkt cap $24 M

Jin Medical reported first half fiscal 2026 earnings on August 4th after market close, likely triggering the 31% drop, though the full headline text was truncated and does not disclose specific results or guidance changes.

A major one-day drop of 31% in a NASDAQ-listed medical device company coinciding with earnings release strongly suggests the reported results disappointed the market. However, the provided headline is incomplete and does not specify what those results were, whether guidance was cut, margins contracted, or other material metrics underperformed. For a China-focused rehabilitation equipment provider, typical disappointment catalysts include slower-than-expected China growth, margin compression, increased competition, regulatory headwinds, or guidance reduction. The timing of the earnings release after market close on August 4th (with the stock dropping on August 5th) is consistent with earnings reaction, but without seeing the actual financial metrics or management commentary from the earnings call, we cannot pinpoint the specific driver. The truncated nature of the headline limits our ability to assess the severity or nature of the miss.

SEDG

SolarEdge Technologies IncTechnology

$33.87−$14.98

-30.7%

NASDAQ · Mkt cap $2.1 B

SolarEdge crashed 30.7% despite beating Q2 earnings estimates and returning to profitability, because management issued a weaker-than-expected Q3 guidance citing ongoing weakness in the U.S. residential solar market.

SolarEdge reported strong Q2 results on August 5, 2026: revenue grew 20% year-over-year to $346 million, gross margins expanded to 28.6% for the sixth consecutive quarter, and the company achieved non-GAAP operating profitability—a major milestone in its turnaround strategy. However, these beats were completely overshadowed by management's forward guidance for Q3, which came in below market expectations and highlighted continued deterioration in the U.S. residential solar market, the company's largest segment. The market punished the stock heavily for the cautious outlook, treating the backward-looking beat as less relevant than the forward-looking warning. This dynamic—strong past performance negated by weak future signals—is common when a company's near-term environment is deteriorating faster than earnings improvement can offset.

FBGL

FBS Global Limited Ordinary SharesIndustrials

$0.40−$0.17

-29.3%

NASDAQ · Mkt cap $5.3 M

No news headlines were found in the last 48 hours, so the 29% drop cannot be attributed to any announced event; the cause likely lies in technical selling, delayed news, or broader market factors affecting micro-cap stocks.

The absence of recent headlines from Yahoo Finance RSS in the 48 hours preceding this sharp 29% decline makes it impossible to pinpoint a specific catalyst from disclosed information. FBGL is a micro-cap stock trading at $0.40, which are typically more volatile and susceptible to technical factors, thin liquidity, and sentiment shifts than large-cap names. The drop could reflect delayed disclosure of negative news from earlier periods, profit-taking after a prior rally, a sector-wide pullback affecting small-cap financials or similar names, or shifts in retail or institutional positioning. Without access to earnings reports, regulatory filings, or official announcements released outside the 48-hour window, any explanation remains speculative rather than grounded in fact.

TBLA

Taboola.com Ltd.Communication Services

$3.83−$1.48

-27.8%

NASDAQ · Mkt cap $1.0 B

Taboola reported Q2 earnings that beat profitability measures and raised full-year guidance, but missed revenue expectations and issued weak forward guidance for Q3, triggering the sharp 27.8% selloff despite positive AI and partnership narratives.

Taboola released Q2 2026 results on August 5 with a mixed message that clearly disappointed the market. The company beat on adjusted EBITDA and ex-TAC gross profit and raised full-year guidance on those metrics, supported by AI adoption and major publisher wins. However, revenue came in below Wall Street consensus at $476.8 million (up only 2.4% year-over-year), and the Q3 revenue guidance of $466.5 million underwhelmed investors, signaling a potential slowdown ahead. The company also cited headwinds from a Google policy change and intentional removal of lower-quality inventory. In growth stocks and digital platforms, top-line revenue misses and declining forward guidance typically override profitability beats, especially when growth is decelerating. The disconnect between margin strength and revenue weakness likely caused the sell-off, as investors worry about the durability of the business amid policy and quality challenges.

VPG

Vishay Precision Group IncTechnology

$73.20−$27.81

-27.5%

NYSE · Mkt cap $835 M

VPG dropped 27.5% despite reporting fiscal Q2 results with $96 million in orders described as reflecting "continued strength in key markets," suggesting the market's reaction was driven by guidance, margins, or forward outlook rather than top-line weakness.

The earnings headline on August 5 explicitly states that VPG reported Q2 results and $96 million in orders representing continued strength. A 27.5% single-day crash on what appears to be a positive orders statement is unusual and suggests the market's negative reaction was triggered by details not captured in the headline snippet—most likely a disappointing profit outlook, reduced full-year guidance, margin compression, or concerning commentary on demand beyond Q2. Since the headline focuses only on order strength and not profitability or guidance, the market likely reacted to information in the full earnings release or conference call that contradicted the surface-level strength message. Without access to the complete earnings release, guidance statements, or management commentary, we cannot pinpoint the exact adverse detail, but the scale of the decline indicates a material negative surprise in either profitability, capital allocation, or forward demand expectations.

IPW

iPower Inc.Consumer Cyclical

$0.36−$0.14

-27.5%

NASDAQ · Mkt cap $5.9 M

iPower announced a 1-for-9 reverse stock split on August 5, which typically signals financial distress or continued delisting risk and triggered a sharp 27.47% single-day decline as investors repriced the stock downward following the announcement.

A reverse stock split announcement is the direct catalyst for today's drop. The company announced a 1-for-9 reverse split, meaning every 9 shares held before the split will convert to 1 share after. While reverse splits mechanically adjust share count and price without changing market capitalization, they are widely viewed as negative signals by the market because they are typically pursued by struggling companies facing NASDAQ minimum price requirements to avoid delisting. The stock's current price of $0.36 suggests iPower has been trading near penny-stock levels, making delisting pressure a likely motivation for the split. Investors typically interpret such actions as acknowledgment of fundamental weakness, which explains the sharp single-day selloff. The headline confirms the announcement timing but does not provide additional context on financial performance or the company's stated rationale.

VVOS

Vivos Therapeutics, Inc.Healthcare

$0.34−$0.13

-27.0%

NASDAQ · Mkt cap $3.8 M

Vivos announced two patents for its CARE oral appliance technology on Aug 5, but the stock fell 27% despite this positive IP news, suggesting the market reaction was driven by unrelated negative sentiment or disappointment in execution rather than the patent announcement itself.

The two headlines on Aug 5 both announce the issuance of new US patents that broaden intellectual property protection for Vivos' flagship CARE oral medical device platform for sleep apnea treatment. These are typically positive developments for a medical device company, as they strengthen competitive moat and exclusivity. However, the stock declined sharply on the same day, which creates a disconnect between the news tenor and price action. This suggests either that investors had already priced in positive patent news, that broader market concerns about the company's commercial execution or cash position outweighed IP benefits, or that there is material negative information not captured in these two headlines. Microcap biomedical stocks are also highly sensitive to clinical trial results, reimbursement decisions, or funding needs that might explain a single-day 27% decline.

ASPCR

A SPAC III Acquisition Corp.

$0.11−$0.04

-26.7%

NASDAQ

No news headlines were available in the last 48 hours, so the 26.67% decline cannot be directly attributed to a specific announcement. SPACs typically decline when merger timelines stall, regulatory hurdles emerge, or shareholder redemptions spike.

The absence of recent headlines makes direct causation impossible to establish. ASPCR is a blank-check acquisition vehicle (SPAC), a security class highly sensitive to deal momentum, timeline delays, and redemption activity. SPACs often trade on the credibility and progress of their target acquisition; without news coverage, the decline could reflect a delayed announcement, failed negotiations, increased shareholder redemptions ahead of a vote, extension deadline approaching, or general de-SPAC market weakness. The magnitude of the drop (rank 20 among daily losers) suggests something material rather than random drift, but the absence of public headlines leaves the specific trigger unknown. Institutional or insider trading activity, or negative private communications to investors, could precede public disclosure.

NOTE

FiscalNote Holdings, Inc.Technology

$0.11−$0.04

-26.7%

NYSE · Mkt cap $2.0 M

NOTE stock fell 26.66% likely due to broader market weakness or company-specific concerns ahead of its Q2 earnings report scheduled for August 10, 2026. No material news explaining the sharp decline was provided.

The only headline directly mentioning FiscalNote is the August 3 announcement that it will report Q2 earnings on August 10, a standard disclosure that does not by itself explain a 26.66% single-day drop. The other headline concerns Cipher Digital, a different company entirely, and is unrelated to NOTE. This timing suggests the decline may reflect pre-earnings volatility, market pessimism about forthcoming results, or a separate catalyst not captured in the available headlines. NOTE operates in AI-driven policy intelligence, and micro-cap or lower-priced equities often experience outsized moves on thin trading volume. Without disclosure of earnings preannouncements, guidance cuts, insider selling, or other material events, the specific driver remains unclear.

AMIX

Autonomix Medical, Inc. Common StockHealthcare

$12.07−$3.89

-26.6%

NASDAQ · Mkt cap $5.7 M

Autonomix Medical plunged 26.55% on August 5th despite announcing a favorable U.S. patent expansion on August 4th, suggesting the market reacted negatively to news content, timing, or broader sector/company-specific headwinds unrelated to the patent itself.

The two headlines from the past 48 hours both describe positive intellectual property developments—a new U.S. patent for the company's neuromodulation platform that expands protection for nerve sensing, mapping, and targeted therapy in oncology and pain management. Ordinarily, patent grants strengthen a company's competitive moat and are viewed favorably. However, the 26.55% single-day drop on August 5th occurred after these announcements, suggesting the market either (a) interpreted the news as less significant than hoped, (b) reacted to context or commentary not captured in the headlines (such as analyst downgrade, insider selling, or clinical trial setback), (c) sold on the news after a prior run-up, or (d) responded to unrelated sector weakness or equity market stress. Without earnings results, guidance changes, regulatory actions, or other material news in the provided headlines, the direct cause of the decline remains unclear.

GWAV

Greenwave Technology Solutions, Inc.Industrials

$3.52−$1.24

-26.1%

NASDAQ · Mkt cap $2.9 M

GWAV fell 26% with no news headlines in the last 48 hours, so the catalyst is unknown; the move may reflect delayed market reaction to an older announcement, technical selling, or material information not yet syndicated to Yahoo Finance.

No headlines appeared in the last 48 hours to explain GWAV's 26% single-day drop, which ranks it among the day's largest losers. This disconnect suggests several possibilities. First, material news may have been released outside the RSS feed window or on channels not immediately picked up by Yahoo Finance—earnings misses, guidance cuts, or executive departures sometimes lag in broader syndication. Second, the stock may be responding to technical breakdown, a short-squeeze unwind, or sector-wide selling if GWAV operates in a sector facing headwinds. Third, a significant announcement could have arrived after market close on the previous day and is being repriced intraday. Without access to the company's direct disclosures, investor relations updates, or filing records for this snapshot date, we cannot isolate the cause. Greenwave Technology Solutions operates in a space that could be sensitive to regulatory, contract, or guidance shifts, but those specifics are absent from available headlines.

LMAT

LeMaitre Vascular IncHealthcare

$78.81−$27.12

-25.6%

BLLN

BillionToOne, Inc.Healthcare

$149.91−$35.75

-25.1%

NASDAQ · Mkt cap $4.7 B

BillionToOne reported Q2 2026 earnings and reiterated full-year guidance on August 5th, but the 25% plunge suggests the market viewed either the results or the maintained guidance as disappointing relative to expectations.

The company released second quarter 2026 results and reaffirmed 2026 revenue guidance on the day of the massive selloff. The headline is sparse on specific numbers, but the timing and severity of the decline indicate the market likely found the earnings report or guidance inadequate. For a molecular diagnostics company heavily dependent on prenatal testing, investors may have been concerned about growth trajectory, margin trends, or competitive pressures if results showed slower expansion than anticipated. One recent analyst commentary from Baron Capital asked whether BLLN has growth engines beyond prenatal testing, which hints at potential concerns about concentration risk and future revenue sustainability that could have been reinforced by the earnings disclosure. The maintained guidance without any upward revision or positive surprise may have triggered profit-taking or repositioning among shareholders who had been hoping for better forward signals.

JUNS

Jupiter Neurosciences, Inc.Healthcare

$0.08−$0.03

-25.1%

NASDAQ · Mkt cap $3.7 M

Jupiter Neurosciences announced a reverse stock split effective August 7, 2026, which likely triggered the 25% decline as investors sold ahead of the split, anticipating dilution or signaling financial distress common in reverse split announcements.

The sole news item provided is Jupiter's August 5 announcement of a reverse stock split to take effect August 7. Reverse splits are often interpreted negatively by markets because they typically signal either a company struggling to maintain minimum listing standards or an attempt to manipulate share price perception without improving fundamentals. Investors commonly sell ahead of such splits due to the association with financial distress, failed business performance, or shareholder dilution concerns. The timing of the announcement just before the split takes effect may have concentrated selling pressure into a single trading day. However, the announcement does not provide details on the split ratio, the company's reasoning, or any other fundamental news that would quantify the true economic impact. The decline magnitude and rank as the 26th biggest loser suggests broader market participation in the sell-off, consistent with investor reaction to reverse split announcements in distressed microcap stocks.

NOEMR

CO2 Energy Transition Corp. Right

$0.15−$0.05

-25.0%

NASDAQ

No news headlines were found in the last 48 hours to explain the 25% drop in NOEMR, so the cause remains unclear from public information, though sector rotation or technical selling in low-liquidity microcaps are plausible drivers.

The complete absence of recent news headlines makes it impossible to attribute this sharp decline to a specific catalyst like earnings, guidance, regulatory action, or corporate event. NOEMR is a rights offering vehicle focused on CO2 and energy transition, a sector subject to volatility and policy-dependent sentiment. Rights offerings and shell-stage entities typically trade on thin volume and are susceptible to technical selling, retail flow reversals, or broader sector headwinds that may not generate newsworthy headlines. It is also possible that a negative development, rumor, or announcement appeared on alternative news channels, social media, or company-specific platforms not captured in the Yahoo Finance RSS feed within the 48-hour window. Without access to intraday news, trading halts, or insider activity, attributing the move to investor sentiment shift or forced liquidation would be speculation.

DVLT

Datavault AI IncTechnology

$0.28−$0.09

-24.0%

NASDAQ · Mkt cap $253 M

No news headlines were available in the last 48 hours, so the 24% drop likely reflects either technical selling pressure, sector headwinds, or undisclosed company developments that have not yet been publicly reported.

Datavault AI experienced a significant single-day decline of nearly 24% with no corresponding news coverage in the immediate period. This disconnect between price action and public information makes causation difficult to establish with certainty. For a micro-cap AI company trading at $0.28, typical catalysts for sharp drops include delayed earnings or guidance announcements, insider selling, sector rotation out of speculative AI plays, or adverse developments disclosed through alternative channels before official press releases. Without headlines to anchor the analysis, the move could reflect either routine penny-stock volatility amplified by low liquidity, a technical breakdown of prior support, or material news that has not yet propagated to major financial media feeds.

TDC

Teradata CorpTechnology

$26.17−$8.23

-23.9%

NYSE · Mkt cap $2.7 B

Teradata beat Q2 earnings and raised full-year EPS guidance, but revenue guidance for Q3 appeared soft and full-year revenue outlook remained cautious, triggering a sell-the-news reversal despite the initial 17.8% post-earnings rally.

The headlines establish that Teradata reported a 25.46% earnings beat and 2.91% revenue beat for Q2, with recurring revenue growth and improved margins. The company raised its full-year EPS and profit outlook and launched new AI platform tools. However, multiple sources note that Q3 revenue guidance was described as "soft" and "back-end loaded," and one headline explicitly states revenue was flat year-on-year at $410 million despite consulting revenue declines. The stock initially rose 17.8% after hours but appears to have reversed sharply by market open. The 23.92% intraday decline suggests investors repriced expectations downward after digesting that near-term revenue momentum remains weak and guidance improvements were driven by cost management rather than top-line acceleration.

AEHL

Antelope Enterprise Holdings LimitedIndustrials

$0.34−$0.10

-23.6%

NASDAQ · Mkt cap $6.5 M

Antelope Enterprise Holdings announced a reverse stock split on August 5th, which typically triggers a sharp sell-off as investors react to the dilution signal and delisting risk implications that reverse splits often carry.

The company announced approval of a reverse stock split on the morning of August 5th, coinciding precisely with the 23.55% intraday decline. While the headline is truncated and doesn't specify the split ratio, reverse splits are commonly viewed negatively by the market because they signal financial distress, potential delisting pressure, or shareholder dilution concerns. The stock's placement at rank 30 among daily losers and its sub-dollar price point ($0.34) suggest AEHL is a micro-cap trading near penny-stock territory, where reverse splits are frequently employed as a last-resort tactic to maintain exchange compliance. Institutional and retail investors typically sell preemptively on such announcements, expecting further downside or dilution. The move is almost certainly a direct reaction to the reverse split announcement rather than an unrelated market factor.

TJGC

TJGC Group LimitedCommunication Services

$4.11−$1.26

-23.5%

NASDAQ · Mkt cap $44 M

No news headlines were available in the last 48 hours, so the 23.49% drop cannot be directly attributed to a specific announced catalyst; the decline likely stems from technical selling, market sentiment, or untracked developments.

The absence of recent news headlines makes it impossible to pinpoint a definitive cause for TJGC's sharp 23.49% decline on August 5, 2026. For a stock ranked among the day's 31 biggest losers, such a large single-day drop typically correlates with material corporate events—earnings misses, guidance cuts, insider selling disclosures, regulatory actions, or sector-wide downturns. Without access to those specific catalysts, we can only infer probable categories: TJGC may have experienced a delayed earnings report or conference announcement that fell outside the news feed window, encountered technical selling after a recent run-up, faced short covering reversals, or been caught in a broader market or sector rotation. The lack of detectable news also raises the possibility of rumor-driven selling or intraday developments that had not yet reached major financial news aggregators by the snapshot date.

GYGY

Game Your Game, Inc.Technology

$3.24−$0.96

-23.3%

NASDAQ · Mkt cap $25 M

Game Your Game Inc. dropped 23.32% on August 5, 2026, with no news headlines available in the last 48 hours to explain the move, suggesting the driver was likely a technical catalyst, delayed disclosure, or market-wide selloff in a niche sector.

No recent news headlines were found in the Yahoo Finance RSS feed for the last 48 hours, so no specific event such as earnings, guidance, product announcement, or corporate action can be directly tied to the decline. Game Your Game Inc. operates in gaming and interactive entertainment, sectors that can experience sharp moves on technical factors, insider activity disclosures, short covering reversals, or delayed news circulation. The magnitude of the drop, 23.32%, is substantial enough to suggest either a company-specific adverse event not yet picked up by major news wires, broad sector weakness in gaming stocks on that date, or a technical unwind in a lower-liquidity name. Without corroborating headlines, the specific catalyst remains unknown.

ANGI

ANGI Homeservices IncCommunication Services

$4.79−$1.43

-22.9%

NASDAQ · Mkt cap $195 M

Angi reported Q2 revenue that missed estimates, declined 11% year-over-year to $248 million, and posted a GAAP loss of $5.70 per share, triggering a 22.95% stock decline despite management highlighting AI initiatives and July EBITDA margin improvements.

The stock fell sharply following Angi's second-quarter earnings release on August 4-5, 2026. The company missed revenue expectations by 5% and delivered a 45% earnings surprise (negative). Revenue dropped 10.9% year-over-year as the company intentionally shifted away from lower-quality marketing channels and network channels, resulting in top-line contraction. While management framed the quarter positively, highlighting an AI-driven strategic pivot, a large pro segment showing early promise, and July EBITDA margins expanding 700 basis points, these forward-looking signals were insufficient to offset the immediate earnings miss and significant per-share loss. The market appears to have punished the company for near-term revenue weakness and GAAP losses, despite management's assertion that the company is repositioning for long-term profitability.

BRUNW

Boost Run Inc. Warrant

$8.64−$2.54

-22.7%

LegalZoom.com, Inc.Industrials

$8.11−$1.91

-22.7%

NASDAQ · Mkt cap $1.1 B

LegalZoom reported Q2 revenue in line with expectations but issued weak Q3 guidance of $194 million, triggering a 22.7% stock decline as investors repriced growth expectations downward despite strong subscription momentum.

LegalZoom's earnings results present a mixed picture that appears to have spooked the market. Revenue of $205.3 million met consensus expectations with 6.6-7% year-over-year growth, and subscription revenue showed encouraging strength with 11% year-over-year growth marking the fifth consecutive quarter of double-digit subscription expansion. However, the forward guidance appears to be the primary culprit. Management guided Q3 revenue to $194 million, which represents a sequential decline from Q2 and signals a meaningful slowdown in growth trajectory. This deceleration likely disappointed growth-oriented investors who may have expected guidance consistent with the subscription acceleration narrative. The positive news about the Microsoft 365 Copilot integration announced August 4th appears insufficient to offset the guidance disappointment, suggesting investors are focused on near-term revenue headwinds rather than longer-term AI partnership potential.

CRTO

Criteo SACommunication Services

$17.01−$5.08

-22.7%

NASDAQ · Mkt cap $890 M

Criteo's Q2 earnings fell short of guidance due to reduced spending from large Performance Media clients and softer demand in certain verticals, despite long-term growth drivers like OpenAI partnership and Retail Media momentum. This miss triggered the 22.68% stock decline.

The earnings headlines establish that Criteo reported Q2 results that fell short of its own expectations, with a 12% decline in contribution ex-TAC attributed to client-specific issues and reduced spending from major Performance Media clients coupled with softer demand in certain verticals. While the company highlighted positive long-term drivers including its OpenAI partnership and Retail Media momentum, the near-term revenue and profitability miss appears to have dominated investor sentiment, driving the sharp selloff. The CFO appointment on the same day may signal operational changes but does not offset the earnings disappointment. The magnitude of the decline ranks it as the 36th biggest loser of the day, suggesting broad market recognition of the earnings shortfall as material.

MTNE.WT

CH4 Natural Solutions Corp WT

$0.25−$0.07

-21.9%

LTCH

Latch, Inc.Technology

$0.14−$0.04

-21.9%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours to explain Latch's 21.88% decline, making the exact catalyst unclear; the drop may reflect broader market conditions, technical selling, or unreported developments.

Latch experienced a sharp single-day loss of approximately 22% with no corresponding headlines in the provided news feed from the past two days. This absence of reported catalyst is notable for a move of this magnitude. Latch operates in the smart access and proptech space, which can be sensitive to interest rate expectations, venture capital sentiment, and commercial real estate conditions. Without concrete news, the decline could reflect several typical patterns for smaller-cap tech stocks: technical breakdown below a key support level, margin-driven selling tied to broader market weakness, delayed market reaction to an announcement made before the news window, or negative sentiment in related sectors. It is also possible that relevant news exists but simply was not captured in the Yahoo Finance RSS feed during the snapshot period.

ADV

Advantage Solutions IncCommunication Services

$32.81−$8.79

-21.1%

NASDAQ · Mkt cap $454 M

Advantage Solutions fell 21% after reporting Q2 earnings showing adjusted EBITDA declined 12% year-over-year despite revenue growth, as weakness in Branded Services and execution challenges offset strong experiential demand and AI-driven gains.

ADV released Q2 2026 results on August 5 showing net revenue of $757 million, up 3% annually, but adjusted EBITDA fell 12% to $76 million. The headlines identify two offsetting forces: positive momentum from Experiential Services and AI-driven efficiency gains, countered by material headwinds in Branded Services and Retailer Services execution challenges. The company reiterated full-year guidance, suggesting management expects conditions to stabilize, yet the sharp profitability decline despite revenue growth signals margin compression that the market penalized heavily. The earnings surprise metric of -317.88% on earnings versus +3.03% on revenue underscores that the bottom-line miss was dramatic relative to top-line performance, likely triggering the 21% single-day selloff.

TYRA

Tyra Biosciences, Inc.Healthcare

$25.73−$6.80

-20.9%

NASDAQ · Mkt cap $1.5 B

Tyra Biosciences fell 20.89% on August 5th following its Q2 2026 earnings release on August 4th, indicating the financial results or guidance disappointed investors despite the company being a clinical-stage biotech focused on FGFR-targeted precision medicines.

The headline confirms Tyra reported second quarter 2026 financial results on August 4th after market close, with the stock dropping sharply the following day. The headline text is truncated and does not provide specific figures, guidance changes, clinical trial outcomes, or management commentary that would explain the magnitude of the decline. For a clinical-stage biotechnology company, the most likely catalysts for a 20% single-day drop would be: (1) disappointing or delayed clinical trial data in their FGFR programs, (2) negative guidance or loss of cash runway expectations, (3) leadership changes, or (4) competitive setbacks in the FGFR space. Without access to the full earnings call or detailed results, the precise reason remains unclear, though the timing correlation between the August 4th release and August 5th decline strongly suggests the earnings announcement was the trigger rather than external market factors.

PODD

Insulet CorpHealthcare

$133.14−$33.66

-20.2%

HUBS

HubSpot IncTechnology

$250.19−$49.98

-20.1%

NYSE · Mkt cap $12 B

HubSpot reported Q2 2026 earnings today alongside a board appointment, but the headlines provided do not disclose specific financial metrics, guidance changes, or miss/beat details that would definitively explain the 20% drop.

HubSpot announced Q2 2026 results and a new board member (Jerry Dischler) on August 5, 2026, the exact day of the 20% decline. However, the news summaries lack the critical financial data—revenue, earnings per share, guidance, margins, customer growth rates—needed to pinpoint what disappointed the market. The prior day's headline noted software stocks "skyrocket" due to easing geopolitical tensions and AI-driven M&A, suggesting positive sector momentum that may have reversed. The Chief Legal Officer's routine tax-withholding share sale is immaterial to a 20% move. Without access to the actual earnings statement details, the most likely categories are: (1) earnings or revenue miss relative to consensus, (2) negative forward guidance or deceleration signals, or (3) margin compression or cash flow concerns. Competitor Klaviyo's AI acquisition announcement on the same day may have also highlighted execution gaps at HubSpot relative to peers.

APP

AppLovin CorporationCommunication Services

$417.81−$86.71

-20.0%

NASDAQ · Mkt cap $103 B

AppLovin reported second-quarter revenue of $1.92 billion, missing Wall Street expectations, and provided soft forward guidance for Q3 at $2.07 billion, triggering a sharp 20% sell-off despite strong year-over-year growth and profit expansion.

The earnings miss is the clear catalyst. AppLovin delivered 52.8% YoY sales growth to $1.92 billion, but this came in below consensus estimates. More importantly, management's Q3 revenue guidance of $2.07 billion disappointed investors who had priced in higher expectations. Multiple sources note that the profit growth was strong yet insufficient to offset the top-line shortfall and cautious forward outlook. The stock initially fell 20-24% in after-hours trading on August 5, closing down approximately 20% on the day. This reflects a classic Wall Street dynamic where growth stocks face harsh repricing when forward guidance signals a deceleration or miss, regardless of historical performance or near-term profitability. The market had apparently built in assumptions about sustained acceleration that management's guidance did not validate.

NXTT

Next Technology Holding Inc.Technology

$0.09−$0.02

-19.3%

NASDAQ · Mkt cap $9.8 M

No headlines were found in the last 48 hours, so the 19% drop cannot be directly attributed to a specific news event. The decline likely reflects technical selling, market sentiment, or undisclosed company developments.

The absence of any recent headlines on Yahoo Finance makes it difficult to pinpoint a concrete cause for NXTT's 19.26% single-day decline. For a micro-cap stock trading at $0.09, moves of this magnitude can be driven by several factors: retail trading volatility and thin liquidity are typical for penny stocks, technical chart breaks below support levels can trigger cascading selling, broader market weakness in the sector or overall market pullback, or negative company announcements that may not yet have reached major news feeds. Without access to company filings, press releases from the issuer's own channels, or social media discussion, it is impossible to determine whether this was fundamental (execution issues, financing struggles, personnel changes) or purely technical and sentiment-driven. The stock's rank as the 44th biggest loser suggests this was a notable intraday move but not market-leading in scope.

ATHHF

Aether Catalyst Solutions Inc.Consumer Cyclical

$0.01−$0.00

-19.2%

PAMT

PAMT CORPIndustrials

$14.30−$3.37

-19.1%

NASDAQ · Mkt cap $248 M

PAMT reported a $7.4 million net loss for Q2 2026 with a 110.6% adjusted truck-load operating ratio, indicating ongoing unprofitability despite fleet restructuring efforts, triggering the 19% sell-off.

PAMT released second-quarter earnings on August 4 showing a consolidated net loss of $7.4 million, or $0.36 loss per share. The company is a truckload carrier attempting to return to profitability by culling its fleet, but the 110.6% adjusted TL operating ratio (a key metric in trucking where below 100% indicates profitability) reveals the carrier remains deeply unprofitable. The operating ratio has actually worsened, suggesting cost-cutting measures are not yet translating to operational improvement. For a company in a capital-intensive, thin-margin industry like trucking, continued losses and deteriorating unit economics trigger investor concern about cash burn, balance sheet stability, and the timeline to profitability, justifying a sharp equity sell-off.

EXTR

Extreme Networks IncEnergy

$26.17−$6.16

-19.1%

NASDAQ · Mkt cap $2.9 B

Extreme Networks reported record revenue, 13% annual growth, and beat earnings estimates on August 5, yet the stock fell 19% the same day, suggesting the market's expectations were set even higher or guidance for fiscal 2027 disappointed relative to the strong Q4 beat.

The earnings headlines describe clear outperformance: Q4 revenue of $339 million beat estimates by 1.48%, EPS beat by 10.35%, annual revenue grew 13%, and SaaS ARR climbed 18% with strong fiscal 2027 outlook cited. These are typically positive catalysts. However, a 19% same-day decline despite multiple earnings-beat headlines suggests the market had priced in even more substantial growth or margin expansion. The most likely explanation is that management's forward guidance for fiscal 2027, while described as strong in headlines, fell short of Wall Street consensus expectations. Alternatively, gross margin expansion or revenue growth deceleration relative to analyst models could have triggered the selloff. Without the actual guidance numbers or analyst reactions, we cannot pinpoint the specific disappointment, but the magnitude of the drop indicates a significant guidance or outlook miss rather than a fundamentals problem.

BrightView Holdings IncIndustrials

$10.62−$2.47

-18.9%

NYSE · Mkt cap $1.0 B

BrightView missed both Q3 earnings and revenue estimates, with earnings beating expectations by -39.29% while revenue fell short, combined with elevated fuel costs and a non-routine self-insurance charge that compressed profitability.

The headlines establish a clear earnings miss on August 4-5. BrightView reported Q3 revenue that fell short of Wall Street expectations, with earnings performing significantly worse at a negative 39.29% surprise. The company's land maintenance business showed growth, but this was overwhelmed by elevated fuel costs and a non-routine self-insurance adjustment that weighed materially on profitability. An 18.87% single-day drop ranks as the 48th worst performer, which is proportionate to an earnings miss of this magnitude in a mid-cap industrial services company. The headlines do not indicate any forward guidance cut or structural deterioration beyond the current quarter, so the market is primarily repricing based on near-term profitability shortfall rather than a reset of long-term expectations.

Chemours Co-TheBasic Materials

$14.58−$3.36

-18.7%

NYSE · Mkt cap $2.3 B

Chemours plunged 18.73% after reporting mixed Q2 earnings that missed revenue estimates, beat EBITDA expectations, but most critically slashed full-year guidance due to aftermarket destocking and weak residential air-conditioning demand.

The earnings release on August 4-5 reveals the core catalyst: Chemours beat EBITDA on pricing strength and APM growth, but missed both earnings and revenue estimates by 2.33% and 4.97% respectively for Q2 2026. More damaging, the company cut full-year guidance, citing destocking in its Thermal & Specialized Solutions (TSS) aftermarket segment and soft residential air-conditioning demand. The headline "Why Chemours Plunged on Wednesday" explicitly states the company delivered "lackluster second quarter" performance relative to investor enthusiasm for its AI business. The dividend announcement on August 4 appears routine and likely provides no offset to the guidance reduction. The earnings miss combined with forward guidance reduction explains the severity of the selloff.

BBBY.WT

Bed Bath & Beyond, Inc. WT

$0.36−$0.08

-17.7%